About: Indaptus Therapeutics, Inc., a clinical biotechnology company, engages in the development of various anti-cancer and anti-viral immunotherapy products. Its lead clinical candidate consists of Decoy20, which is used to produce single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, and chronic hepatitis B virus, and human immunodeficiency virus infection, as well as for the treatment of advanced solid tumors. The company was formerly known as Intec Parent, Inc. and changed its name to Indaptus Therapeutics, Inc. in August 2021. Indaptus Therapeutics, Inc. is headquartered in New York, New York.
Sector: Healthcare
Industry: Biotechnology
Latest price: $2.46 (+0.82%)
INDP NASDAQ Indaptus Therapeutics Inc
Indaptus Therapeutics Inc share price
INDP price activity
Last Price
$2.460
Change (24hr)
0.02 USD (0.82%)
Volume
29.02K
Volume (4w avg)
-
Open
$2.44
Day Range
$2.40 - $2.52
Previous Close
$2.44
Last Trade
13 Oct, 3:22 pm GMT+0
Delayed
13 Oct, 3:22 pm GMT+0
INDP price performance
Delayed
13 Oct, 3:22 pm GMT+0
INDP Market Signals